Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on Septembe...( WALTHAM Mass. Sept. 16 /- Inverne...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
Date:9/16/2008
WALTHAM, Mass., Sept. 16 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, today announced that Ron Zwanziger, Chairman, Chief Executive Officer and President, and Jon Russell, Vice President, Finance, will be attending the Goldman Sachs Diagnostics Conference on Thursday, September 18, 2008 in New York City in order to meet with current and prospective investors. A company presentation is not planned.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. For more information about Inverness Medical Innovations, please visit http://www.invmed.com.
'/>"/>
| SOURCE Inverness Medical Innovations, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
2. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
3. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
4. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
5. Inverness Medical Innovations Announces Second Quarter 2008 Results
6. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
7. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
8. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
9. Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
10. Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30, 2008
11. Inverness Medical Innovations Announces First Quarter 2008 Results
Post Your Comments:
Breaking Biology Technology:PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision 2Vivakor Announces Mechanics of Dividend Distribution 2Vivakor Announces Mechanics of Dividend Distribution 3Eidogen-Sertanty Licenses TIP to the FDA 2HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 2HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 3
Other Biology Technology:Case Western Reserve University researcher improves LCDs with 3-D nanoimaging process 2Case Western Reserve University researcher improves LCDs with 3-D nanoimaging process 3Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results 2Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting 3
Case Western Reserve University researcher improves LCDs with 3-D nanoimaging processInverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 ResultsOncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
Breaking Biology News(10 mins):Brooding fishes take up nutrients from their own children 2Researchers finds hidden sensory system in the skin 2Researchers finds hidden sensory system in the skin 3Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2Diamond Honing Tool Technology 3A The New Standard in Surface Finishing of Hard Materials 61037 1Diamond Honing Tool Technology 3A The New Standard in Surface Finishing of Hard Materials 61037 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 1Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 3Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 4Some chest pain patients wait longer than 10 minutes to see ER physician 61033 1Some chest pain patients wait longer than 10 minutes to see ER physician 61033 2
Other Biology News:Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3AACR, BCRF award inaugural grants in translational breast cancer research 2AACR, BCRF award inaugural grants in translational breast cancer research 3Biopharmaceutical infrastructure key to lower drug development costs 2
Biology Products:
Equine Immunoglobulin G from Equitech-BioMouse Anti-SALMONELLA HADAR Monoclonal Antibody, Unconjugated, Clone 37/252 from AbD SerotecMouse Anti-Human IFN-Gamma RC2 (CD118) Non-Neutralizing Monoclonal Antibody, Unconjugated, Clone MMHGR-2 from PBL InterferonSourceSecure-Seal™ hybridization chamber gasket, eight chambers, 9 mm diameter, 0.8 mm deep *set of 20* from Molecular Probes (Invitrogen)
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |